Recent News

• 03.26.2026 - Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025
• 03.10.2026 - Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing
• 03.05.2026 - Dermata Opens a New Chapter with the Release of Tome Skincare
• 01.20.2026 - Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office

Recent Filings

• 03.17.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.25.2026 - 8-K Current report
• 02.23.2026 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 02.18.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.17.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.09.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.03.2026 - 8-K Current report
• 02.02.2026 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 01.29.2026 - 424B3 Prospectus [Rule 424(b)(3)]
• 01.29.2026 - EFFECT Notice of Effectiveness